Skip to content
Opens in a new window
Parkinsonism and Immune Checkpoint Inhibitors, Artificial Intelligence in Administration, SECmeres Discovery
05 November 2026

Parkinsonism and Immune Checkpoint Inhibitors, Artificial Intelligence in Administration, SECmeres Discovery

Neurology Today in 5

About

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about parkinsonism as a side effect of immune checkpoint inhibitors, artificial intelligence's use as an administrative tool, and how SECmeres could help with Alzheimer's disease diagnoses.